Glucuronoxylomannan, galactoxylomannan, and mannoprotein occupy spatially separate and discrete regions in the capsule of Cryptococcus neoformans

References

• Yauch LE, Mansour MK, Levitz SM. Receptor-mediated clearance of Cryptococcus neoformans capsular polysaccharide in vivo. Infect Immun 2005; 73:8429 - 8432
   PubMed Web of Science ®Google Scholar
• Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS—100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 1995; 8:515 - 548
   PubMed Web of Science ®Google Scholar
• Rivera J, Mukherjee J, Weiss LM, Casadevall A. Antibody efficacy in murine pulmonary Cryptococcus neoformans infection: a role for nitric oxide. J Immunol 2002; 168:3419 - 3427
   PubMed Web of Science ®Google Scholar
• Schop J. Protective immunity against Cryptococcus neoformans infection. Mcgill J Med 2007; 10:35 - 43
   PubMedGoogle Scholar
• Mukherjee J, Casadevall A, Scharff MD. Molecular characterization of the humoral responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization. J Exp Med 1993; 177:1105 - 1116
   PubMed Web of Science ®Google Scholar
• McFadden D, Zaragoza O, Casadevall A. The capsular dynamics of Cryptococcus neoformans. Trends Microbiol 2006; 14:497 - 505
   PubMed Web of Science ®Google Scholar
• Vaishnav VV, Bacon BE, O'Neill M, Cherniak R. Structural characterization of the galactoxylomannan of Cryptococcus neoformans Cap67. Carbohydr Res 1998; 306:315 - 330
   PubMed Web of Science ®Google Scholar
• Levitz SM, Specht CA. The molecular basis for the immunogenicity of Cryptococcus neoformans mannoproteins. FEMS Yeast Res 2006; 6:513 - 524
   PubMed Web of Science ®Google Scholar
• Heiss C, Klutts JS, Wang Z, Doering TL, Azadi P. The structure of Cryptococcus neoformans galactoxylomannan contains beta-D-glucuronic acid. Carbohydr Res 2009; 344:915 - 920
   PubMed Web of Science ®Google Scholar
• De Jesus M, Chow SK, Cordero RJ, Frases S, Casadevall A. Galactoxylomannans from Cryptococcus neoformans varieties neoformans and grubii are structurally and antigenically variable. Eukaryot Cell 9:1018 - 1028
   PubMed Web of Science ®Google Scholar
• Frases S, Nimrichter L, Viana NB, Nakouzi A, Casadevall A. Cryptococcus neoformans capsular polysaccharide and exopolysaccharide fractions manifest physical, chemical and antigenic differences. Eukaryot Cell 2008; 7:319 - 327
   PubMed Web of Science ®Google Scholar
• James PG, Cherniak R, Jones RG, Stortz CA, Reiss E. Cell-wall glucans of Cryptococcus neoformans Cap 67. Carbohydr Res 1990; 198:23 - 38
   PubMed Web of Science ®Google Scholar
• Vartivarian SE, Reyes GH, Jacobson ES, James PG, Cherniak R, Mumaw VR, Tingler MJ. Localization of mannoprotein in Cryptococcus neoformans. J Bacteriol 1989; 171:6850 - 6852
   PubMed Web of Science ®Google Scholar
• Murphy JW. Influence of cryptococcal antigens on cellmediated immunity. Rev Infect Dis 1988; 10:432 - 435
   PubMedGoogle Scholar
• Reiss E, Huppert M, Cherniak R. Characterization of protein and mannan polysaccharide antigens of yeasts, moulds and actinomycetes. Curr Top Med Mycol 1985; 1:172 - 207
   PubMedGoogle Scholar
• Eigenheer RA, Jin Lee Y, Blumwald E, Phinney BS, Gelli A. Extracellular glycosylphosphatidylinositol-anchored mannoproteins and proteases of Cryptococcus neoformans. FEMS Yeast Res 2007; 7:499 - 510
   PubMed Web of Science ®Google Scholar
• Specht CA, Nong S, Dan JM, Lee CK, Levitz SM. Contribution of glycosylation to T cell responses stimulated by recombinant Cryptococcus neoformans mannoprotein. J Infect Dis 2007; 196:796 - 800
   PubMed Web of Science ®Google Scholar
• Chaka W, Verheul AF, Vaishnav VV, Cherniak R, Scharringa J, Verhoef J, et al. Induction of TNFalpha in human peripheral blood mononuclear cells by the mannoprotein of Cryptococcus neoformans involves human mannose binding protein. J Immunol 1997; 159:2979 - 2985
   PubMed Web of Science ®Google Scholar
• Murphy JW, Mosley RL, Cherniak R, Reyes GH, Kozel TR, Reiss E. Serological, electrophoretic and biological properties of Cryptococcus neoformans antigens. Infect Immun 1988; 56:424 - 431
   PubMed Web of Science ®Google Scholar
• Delfino D, Cianci L, Lupis E, Celeste A, Petrelli ML, Curro F, et al. Interleukin-6 production by human monocytes stimulated with Cryptococcus neoformans components. Infect Immun 1997; 65:2454 - 2456
   PubMed Web of Science ®Google Scholar
• Pitzurra L, Perito S, Baldelli F, Bistoni F, Vecchiarelli A. Humoral response against Cryptococcus neoformans mannoprotein antigens in HIV-infected patients. Clin Exp Immunol 2003; 133:91 - 96
   PubMed Web of Science ®Google Scholar
• Pietrella D, Mazzolla R, Lupo P, Pitzurra L, Gomez MJ, Cherniak R, et al. Mannoprotein from Cryptococcus neoformans promotes T-helper type 1 anticandidal responses in mice. Infect Immun 2002; 70:6621 - 6627
   PubMed Web of Science ®Google Scholar
• Pietrella D, Cherniak R, Strappini C, Perito S, Mosci P, Bistoni F, et al. Role of mannoprotein in induction and regulation of immunity to Cryptococcus neoformans. Infect Immun 2001; 69:2808 - 2814
   PubMed Web of Science ®Google Scholar
• Vecchiarelli A. Immunoregulation by capsular components of Cryptococcus neoformans. Med Mycol 2000; 38:407 - 417
   PubMed Web of Science ®Google Scholar
• Pitzurra L, Cherniak R, Giammarioli M, Perito S, Bistoni F, Vecchiarelli A. Early induction of interleukin-12 by human monocytes exposed to Cryptococcus neoformans mannoproteins. Infect Immun 2000; 68:558 - 563
   PubMed Web of Science ®Google Scholar
• Dan JM, Wang JP, Lee CK, Levitz SM. Cooperative stimulation of dendritic cells by Cryptococcus neoformans mannoproteins and CpG oligodeoxynucleotides. PLoS ONE 2008; 3:2046
   PubMed Web of Science ®Google Scholar
• Mansour MK, Schlesinger LS, Levitz SM. Optimal T cell responses to Cryptococcus neoformans mannoprotein are dependent on recognition of conjugated carbohydrates by mannose receptors. J Immunol 2002; 168:2872 - 2879
   PubMed Web of Science ®Google Scholar
• Levitz SM, Nong S, Mansour MK, Huang C, Specht CA. Molecular characterization of a mannoprotein with homology to chitin deacetylases that stimulates T cell responses to Cryptococcus neoformans. Proc Natl Acad Sci USA 2001; 98:10422 - 10427
   PubMed Web of Science ®Google Scholar
• Baker LG, Specht CA, Donlin MJ, Lodge JK. Chitosan, the deacetylated form of chitin, is necessary for cell wall integrity in Cryptococcus neoformans. Eukaryot Cell 2007; 6:855 - 867
   PubMed Web of Science ®Google Scholar
• Casadevall A, Mukherjee J, Devi SJ, Schneerson R, Robbins JB, Scharff MD. Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection. J Infect Dis 1992; 165:1086 - 1093
   PubMed Web of Science ®Google Scholar
• De Jesus M, Nicola AM, Rodrigues ML, Janbon G, Casadevall A. Capsular localization of the Cryptococcus neoformans polysaccharide component galactoxylomannan. Eukaryot Cell 2009; 8:96 - 103
   PubMed Web of Science ®Google Scholar
• Orendi JM, Verheul AF, De Vos NM, Visser MR, Snippe H, Cherniak R, et al. Mannoproteins of Cryptococcus neoformans induce proliferative response in human peripheral blood mononuclear cells (PBMC) and enhance HIV-1 replication. Clin Exp Immunol 1997; 107:293 - 299
   PubMed Web of Science ®Google Scholar
• Turner SH, Cherniak R, Reiss E. Fractionation and characterization of galactoxylomannan from Cryptococcus neoformans. Carbohydr Res 1984; 125:343 - 349
   PubMed Web of Science ®Google Scholar
• Zaragoza O, Fries BC, Casadevall A. Induction of capsule growth in Cryptococcus neoformans by mammalian serum and CO(2). Infect Immun 2003; 71:6155 - 6164
   PubMed Web of Science ®Google Scholar
• Casadevall A, Cleare W, Feldmesser M, Glatman-Freedman A, Goldman DL, Kozel TR, et al. Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrob Agents Chemother 1998; 42:1437 - 1446
   PubMed Web of Science ®Google Scholar
• Mondon P, Chang YC, Varma A, Kwon-Chung KJ. A novel episomal shuttle vector for transformation of Cryptococcus neoformans with the ccdB gene as a positive selection marker in bacteria. FEMS Microbiol Lett 2000; 187:41 - 45
   PubMed Web of Science ®Google Scholar
• Wickes BL, Edman U, Edman JC. The Cryptococcus neoformans STE12alpha gene: a putative Saccharomyces cerevisiae STE12 homologue that is mating type specific. Mol Microbiol 1997; 26:951 - 960
   PubMed Web of Science ®Google Scholar
• Wickes BL, Edman JC. The Cryptococcus neoformans GAL7 gene and its use as an inducible promoter. Mol Microbiol 1995; 16:1099 - 1109
   PubMed Web of Science ®Google Scholar